Delayed Enhancement of Intracranial Atherosclerotic Plaque Can Better Differentiate Culprit Lesions: A Multiphase Contrast-Enhanced Vessel Wall MRI Study

References

1. 1.↵
   1. Arenillas JF

   . Intracranial atherosclerosis: current concepts. Stroke 2011;42:S20–3 doi:10.1161/STROKEAHA.110.597278 pmid:21164126

   Abstract/FREE Full Text
2. 2.↵
   1. White H,
   2. Boden-Albala B,
   3. Wang C, et al

   . Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 2005;111:1327–31 doi:10.1161/01.CIR.0000157736.19739.D0 pmid:15769776

   Abstract/FREE Full Text
3. 3.↵
   1. Wong KS,
   2. Huang YN,
   3. Gao S, et al

   . Intracranial stenosis in Chinese patients with acute stroke. Neurology 1998;50:812–13 doi:10.1212/wnl.50.3.812 pmid:9521286

   CrossRefPubMed
4. 4.↵
   1. de Havenon A,
   2. Mossa-Basha M,
   3. Shah L, et al

   . High-resolution vessel wall MRI for the evaluation of intracranial atherosclerotic disease. Neuroradiology 2017;59:1193–202 doi:10.1007/s00234-017-1925-9 pmid:28942481

   CrossRefPubMed
5. 5.↵
   1. Mossa-Basha M,
   2. Alexander M,
   3. Gaddikeri S, et al

   . Vessel wall imaging for intracranial vascular disease evaluation. J Neurointerv Surg 2016;8:1154–59 doi:10.1136/neurintsurg-2015-012127 pmid:26769729

   Abstract/FREE Full Text
6. 6.↵
   1. Alexander MD,
   2. de Havenon A,
   3. Kim SE, et al

   . Assessment of quantitative methods for enhancement measurement on vessel wall magnetic resonance imaging evaluation of intracranial atherosclerosis. Neuroradiology 2019;61:643–50 doi:10.1007/s00234-019-02167-3 pmid:30675639

   CrossRefPubMed
7. 7.↵
   1. Dieleman N,
   2. Yang W,
   3. Abrigo JM, et al

   . Magnetic resonance imaging of plaque morphology, burden, and distribution in patients with symptomatic middle cerebral artery stenosis. Stroke 2016;47:1797–802 doi:10.1161/STROKEAHA.116.013007 pmid:27301944

   Abstract/FREE Full Text
8. 8.↵
   1. Gorelick PB,
   2. Wong KS,
   3. Bae HJ, et al

   . Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 2008;39:2396–99 doi:10.1161/STROKEAHA.107.505776 pmid:18535283

   Abstract/FREE Full Text
9. 9.↵
   1. Portanova A,
   2. Hakakian N,
   3. Mikulis DJ, et al

   . Intracranial vasa vasorum: insights and implications for imaging. Radiology 2013;267:667–79 doi:10.1148/radiol.13112310 pmid:23704290

   CrossRefPubMed
10. 10.↵
    1. Qiao Y,
    2. Zeiler SR,
    3. Mirbagheri S, et al

    . Intracranial plaque enhancement in patients with cerebrovascular events on high-spatial-resolution MR images. Radiology 2014;271:534–42 doi:10.1148/radiol.13122812 pmid:24475850

    CrossRefPubMed
11. 11.↵
    1. Wang E,
    2. Shao S,
    3. Li S, et al

    . A high-resolution MRI study of the relationship between plaque enhancement and ischemic stroke events in patients with intracranial atherosclerotic stenosis. Front Neurol 2018;9:1154 doi:10.3389/fneur.2018.01154 pmid:30671018

    CrossRefPubMed
12. 12.↵
    1. Kim JM,
    2. Jung KH,
    3. Sohn CH, et al

    . Intracranial plaque enhancement from high resolution vessel wall magnetic resonance imaging predicts stroke recurrence. Int J Stroke 2016;11:171–79 doi:10.1177/1747493015609775 pmid:26783308

    CrossRefPubMed
13. 13.↵
    1. Song X,
    2. Zhao X,
    3. Liebeskind DS, et al

    . Incremental value of plaque enhancement in predicting stroke recurrence in symptomatic intracranial atherosclerosis. Neuroradiology 2020;62:1123–31 doi:10.1007/s00234-020-02418-8 pmid:32300828

    CrossRefPubMed
14. 14.↵
    1. Yang D,
    2. Liu J,
    3. Yao W, et al

    . The MRI enhancement ratio and plaque steepness may be more accurate for predicting recurrent ischemic cerebrovascular events in patients with intracranial atherosclerosis. Eur Radiology 2022;32:7004–13 doi:10.1007/s00330-022-08893-2 pmid:35771249

    CrossRefPubMed
15. 15.↵
    1. Xu C,
    2. Qin J,
    3. Yu J, et al

    . Association of plaque enhancement on vessel wall MRI and the phosphodiesterase 4D variant with stroke recurrence in patients with symptomatic intracranial atherosclerosis. Neuroradiology 2022;64:1781–94 doi:10.1007/s00234-022-02948-3 pmid:35420310

    CrossRefPubMed
16. 16.↵
    1. van der Kolk AG,
    2. Zwanenburg JJ,
    3. Brundel M, et al

    . Intracranial vessel wall imaging at 7.0-T MRI. Stroke 2011;42:2478–84 doi:10.1161/STROKEAHA.111.620443 pmid:21757674

    Abstract/FREE Full Text
17. 17.↵
    1. Lu SS,
    2. Ge S,
    3. Su CQ, et al

    . MRI of plaque characteristics and relationship with downstream perfusion and cerebral infarction in patients with symptomatic middle cerebral artery stenosis. J Magn Reson Imaging 2018;48:66–73 doi:10.1002/jmri.25879 pmid:29083523

    CrossRefPubMed
18. 18.↵
    1. Li X,
    2. Sun B,
    3. Wang L, et al

    . Association of type 2 diabetes mellitus and glycemic control with intracranial plaque characteristics in patients with acute ischemic stroke. J Magn Reson Imaging 2021;54:655–66 doi:10.1002/jmri.27614 pmid:33786939

    CrossRefPubMed
19. 19.↵
    1. Song JW,
    2. Pavlou A,
    3. Burke MP, et al

    . Imaging endpoints of intracranial atherosclerosis using vessel wall MR imaging: a systematic review. Neuroradiology 2021;63:847–56 doi:10.1007/s00234-020-02575-w pmid:33029735

    CrossRefPubMed
20. 20.↵
    1. Shi Z,
    2. Li J,
    3. Zhao M, et al

    . Quantitative histogram analysis on intracranial atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Stroke 2020;51:2161–69 doi:10.1161/STROKEAHA.120.029062 pmid:32568660

    CrossRefPubMed
21. 21.↵
    1. Wu G,
    2. Wang H,
    3. Zhao C, et al

    . Large culprit plaque and more intracranial plaques are associated with recurrent stroke: a case-control study using vessel wall imaging. AJNR Am J Neuroradiol 2022;43:207–15 doi:10.3174/ajnr.A7402 pmid:35058299

    Abstract/FREE Full Text
22. 22.↵
    1. Ran Y,
    2. Wang Y,
    3. Zhu M, et al

    . Higher plaque burden of middle cerebral artery is associated with recurrent ischemic stroke: a quantitative magnetic resonance imaging study. Stroke 2020;51:659–62 doi:10.1161/STROKEAHA.119.028405 pmid:31856694

    CrossRefPubMed
23. 23.↵
    1. Sun B,
    2. Wang L,
    3. Li X, et al

    . Intracranial atherosclerotic plaque characteristics and burden associated with recurrent acute stroke: a 3D quantitative vessel wall MRI study. Front Aging Neurosci 2021;13:706544 doi:10.3389/fnagi.2021.706544 pmid:34393761

    CrossRefPubMed
24. 24.↵
    1. Wu F,
    2. Ma Q,
    3. Song H, et al

    . Differential features of culprit intracranial atherosclerotic lesions: a whole-brain vessel wall imaging study in patients with acute ischemic stroke. J Am Heart Assoc 2018;7:e009705
25. 25.↵
    1. Vakil P,
    2. Vranic J,
    3. Hurley MC, et al

    . T1 gadolinium enhancement of intracranial atherosclerotic plaques associated with symptomatic ischemic presentations. AJNR Am J Neuroradiol 2013;34:2252–58 doi:10.3174/ajnr.A3606 pmid:23828109

    Abstract/FREE Full Text
26. 26.↵
    1. Skarpathiotakis M,
    2. Mandell DM,
    3. Swartz RH, et al

    . Intracranial atherosclerotic plaque enhancement in patients with ischemic stroke. AJNR Am J Neuroradiol 2013;34:299–304 doi:10.3174/ajnr.A3209 pmid:22859280

    Abstract/FREE Full Text
27. 27.↵
    1. Wang W,
    2. Yang Q,
    3. Li D, et al

    . Incremental value of plaque enhancement in patients with moderate or severe basilar artery stenosis: 3.0 T high-resolution magnetic resonance study. Biomed Res Int 2017;2017:4281629 doi:10.1155/2017/4281629 pmid:29075645

    CrossRefPubMed
28. 28.↵
    1. Vakil P,
    2. Elmokadem AH,
    3. Syed FH, et al

    . Quantifying intracranial plaque permeability with dynamic contrast-enhanced MRI: a pilot study. AJNR Am J Neuroradiol 2017;38:243–49 doi:10.3174/ajnr.A4998 pmid:27856437

    Abstract/FREE Full Text
29. 29.↵
    1. Ntaios G,
    2. Pearce LA,
    3. Meseguer E, et al

    . Aortic arch atherosclerosis in patients with embolic stroke of undetermined source: an exploratory analysis of the NAVIGATE ESUS trial. Stroke 2019;50:3184–90 doi:10.1161/STROKEAHA.119.025813 pmid:31526123

    CrossRefPubMed
30. 30.↵
    1. Wang J,
    2. Yarnykh VL,
    3. Yuan C

    . Enhanced image quality in black-blood MRI using the improved motion-sensitized driven-equilibrium (iMSDE) sequence. J Magn Reson Imaging 2010;31:1256–63 doi:10.1002/jmri.22149 pmid:20432365

    CrossRefPubMed
31. 31.↵
    1. Wang J,
    2. Zhang S,
    3. Lu J, et al

    . High-resolution MR for follow-up of intracranial steno-occlusive disease treated by endovascular treatment. Front Neurol 2021;12:706645 doi:10.3389/fneur.2021.706645 pmid:35002907

    CrossRefPubMed
32. 32.↵
    1. Hartman JB,
    2. Watase H,
    3. Sun J, et al

    . Intracranial aneurysms at higher clinical risk for rupture demonstrate increased wall enhancement and thinning on multicontrast 3D vessel wall MRI. Br J Radiology 2019;92:20180950 doi:10.1259/bjr.20180950 pmid:30653339

    CrossRefPubMed
33. 33.↵
    1. de Havenon A,
    2. Muhina HJ,
    3. Parker DL, et al

    . Effect of time elapsed since gadolinium administration on atherosclerotic plaque enhancement in clinical vessel wall MR imaging studies. AJNR Am J Neuroradiol 2019;40:1709–11 doi:10.3174/ajnr.A6191 pmid:31515211

    Abstract/FREE Full Text
34. 34.↵
    1. Szolar DH,
    2. Korobkin M,
    3. Reittner P, et al

    . Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 2005;234:479–85 doi:10.1148/radiol.2342031876 pmid:15671003

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Kwee RM,
    2. Qiao Y,
    3. Liu L, et al

    . Temporal course and implications of intracranial atherosclerotic plaque enhancement on high-resolution vessel wall MRI. Neuroradiology 2019;61:651–57 doi:10.1007/s00234-019-02190-4 pmid:30834465

    CrossRefPubMed